ISSCR News
The ISSCR Opens 2027 Membership, Introduces $1 Student Membership for Low- and Middle-Income Countries
Join now and receive immediate access to ISSCR member benefits through the end of 2027
The International Society for Stem Cell Research (ISSCR) has opened membership for 2027, with a major new initiative designed to expand access to the global stem cell community. Student membership is now just $1 USD for students studying in low- and middle-income countries, as defined by the World Bank.
The new membership rate reflects the ISSCR’s commitment to supporting the future of stem cell science by making it easier for students around the world to connect with the research, people, and opportunities that can help shape their scientific careers. Through the ISSCR, students can learn from leaders across the field, showcase their own research, build relationships with scientists from around the world, and become part of the global community as they continue their education and pursue careers in stem cell science and regenerative medicine.
Individuals who join or renew now for 2027 begin enjoying the benefits immediately, providing access for the remainder of 2026 and throughout 2027.
Nominations Are Open for the 2027 ISSCR Board of Directors and the Society’s Annual Awards
Nominations are now open for the 2027 ISSCR Board of Directors and the Society’s annual awards.
The strength of the ISSCR comes from the expertise, perspectives, and contributions of its global community. This fall, members have two important opportunities to engage with the Society – helping to shape its future leadership and recognizing individuals and groups whose contributions are advancing stem cell science and the field.
Nominations for both opportunities are due on 16 October 2026.
Stem Cell Reports Welcomes Dominique Bonnet and Frederic Relaix as Associate Editors
Leading researchers bring expertise in hematopoietic and muscle stem cells to the ISSCR’s open access peer-reviewed journal
The International Society for Stem Cell Research (ISSCR) announces the appointment of Dominique Bonnet, Ph.D., and Frederic Relaix, Ph.D., as Associate Editors of Stem Cell Reports, the official journal of the ISSCR.
Drs. Bonnet and Relaix bring internationally recognized expertise spanning hematopoietic and muscle stem cell biology, development, regeneration, disease modeling, and translational research. Their appointments further strengthen the journal’s editorial expertise across fundamental and disease-focused stem cell research.
Stem Cell Model of Diabetic Kidney Disease Identifies Inflammation as Therapeutic Target
Stem cell researchers have identified inflammatory pathways that may play a key role in driving kidney damage in diabetic kidney disease (DKD), pointing to potential new approaches for protecting the kidneys. Using stem cell-derived kidney organoids, Benjamin Freedman and colleagues from the University of Washington, USA, found that exposure to high sugar levels triggered inflammation and disrupted the organoids’ typical kidney tissue-like structure, causing individual kidney cells to detach. These changes were reminiscent of those observed in kidney biopsies and urine samples from patients with DKD. The research was published today in the peer-reviewed journal, Stem Cell Reports.
The ISSCR Responds to FDA’s Draft Guidance on Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing
On 1 September, the ISSCR submitted comments to the Food and Drug Administration’s draft guidance for Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing. ISSCR supports FDA’s desire to share the Agency’s current thinking on the type of prior knowledge (i.e., public and platform knowledge) that may be scientifically appropriate to leverage to advance product development.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .